BRIEF published on 07/23/2026 at 11:10, 2 months 14 days ago FAMAR Appoints Bruce Vielle as New CEO Operational Excellence CEO Appointment Pharmaceutical Manufacturing FAMAR Bruce Vielle
BRIEF published on 07/23/2026 at 11:10, 2 months 14 days ago FAMAR nomme Bruce Vielle au poste de nouveau PDG Excellence Opérationnelle Nomination Du PDG Fabrication Pharmaceutique FAMAR Bruce Vielle
PRESS RELEASE published on 07/23/2026 at 11:05, 2 months 14 days ago FAMAR appoints Bruce Vielle as Chief Executive Officer FAMAR appoints Bruce Vielle as Chief Executive Officer effective 3 August 2026, succeeding Dr Riku Rautsola, with MidEuropa's strong commitment and focus on enhancing capabilities and customer support Appointment CEO FAMAR Bruce Vielle MidEuropa
BRIEF published on 05/19/2026 at 12:10, 4 months 18 days ago FAMAR Group Enters Agreement with GE HealthCare Contract Manufacturing GE HealthCare FAMAR Group Iodine-based Contrast Media Homburg Facility
BRIEF published on 05/19/2026 at 12:10, 4 months 18 days ago Le groupe FAMAR conclut un accord avec GE HealthCare Fabrication Sous Contrat GE Santé Groupe FAMAR Produits De Contraste À Base D'iode Installations De Homburg
PRESS RELEASE published on 05/19/2026 at 12:05, 4 months 18 days ago FAMAR Group announces contract manufacturing agreement with GE HealthCare FAMAR Group signs contract manufacturing agreement with GE HealthCare to fill and finish iodine-based contrast media vials in Homburg, Germany, expanding GE's manufacturing capacity for European customers Contract Manufacturing GE HealthCare FAMAR Group Contrast Media Homburg
BRIEF published on 09/29/2025 at 19:40, 1 year ago FAMAR Group Appoints Dr. Riku Rautsola as New CEO Global Expansion Pharmaceutical Industry CEO Appointment Leadership Change FAMAR Group
BRIEF published on 09/29/2025 at 19:40, 1 year ago Le groupe FAMAR nomme le Dr Riku Rautsola au poste de PDG Changement De Direction Expansion Mondiale Nomination Du PDG Industrie Pharmaceutique Groupe FAMAR
PRESS RELEASE published on 09/29/2025 at 19:35, 1 year ago FAMAR Group: Dr. Riku Rautsola Appointed New CEO FAMAR Group appoints Dr. Riku Rautsola as new CEO, replacing Konstantinos Rengis. Rautsola brings global leadership experience to drive growth and innovation Pharmaceutical Industry CEO Appointment Leadership Change FAMAR Group Dr. Riku Rautsola
Published on 10/06/2026 at 12:00, 23 minutes ago Banyan Gold Intersects 1.88 g/t Gold over 17.9 Metres in the Gap Between Airstrip and Powerline, and Identifies High-Grade Gold in Airstrip Footwall at AurMac, Yukon, Canada
Published on 10/06/2026 at 12:00, 23 minutes ago PJX Resources Secures Permit to Drill High-Priority RIRGS Gold Targets on Zinger Property; Advances Critical Metals Drilling at Dewdney Trail
Published on 10/05/2026 at 22:30, 13 hours 53 minutes ago EV Nickel Announces Formation of Wholly Owned Subsidiary to Advance Nickel Bioleaching Technology and Canadian Nickel Supply Chain
Published on 10/05/2026 at 14:45, 21 hours 38 minutes ago NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
Published on 10/06/2026 at 12:05, 18 minutes ago Solidion Technology (NASDAQ: STI) Sees no Basis to Increase Its Offer to Polar Power, Inc. (NASDAQ: POLA) in Response to Board Rejection of All-Cash Asset Acquisition Proposal
Published on 10/06/2026 at 11:34, 49 minutes ago EQS-Adhoc: Blue Cap AG: Blue Cap AG: Changes to the Management Board
Published on 10/05/2026 at 22:12, 14 hours 11 minutes ago AXA - Elimination of the dilutive impact of Shareplan 2026
Published on 10/05/2026 at 22:12, 14 hours 11 minutes ago AXA - Elimination de l'effet dilutif de l'opération Shareplan 2026
Published on 10/05/2026 at 18:13, 18 hours 10 minutes ago Disclosure of shares outstanding and voting rights - 05.10.2026
Published on 10/05/2026 at 18:13, 18 hours 10 minutes ago Déclaration nombre d'actions et droits de vote - 05.10.2026
Published on 10/05/2026 at 18:00, 18 hours 23 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 septembre 2026
